PortfoliosLab logoPortfoliosLab logo
22526-2
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


GDX 23.93%SIVR 6.18%1 position 2.22%RDIV 48.11%VOO 9.82%16 positions 6.73%1 position 2.87%AlternativesAlternativesCommodityCommodityEquityEquityMulti-AssetMulti-Asset

S&P 500 Index

Portfolio Optimizer

Find the right asset allocation for 22526-2

Add portfolio to the optimizer to find optimal allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in 22526-2, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading charts...

Returns By Period


Position1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
1.65%1.97%10.35%10.82%26.39%19.66%12.33%13.81%
Portfolio
22526-2
0.95%1.83%9.55%10.38%42.17%
ALKS
Alkermes plc
0.18%18.36%58.54%57.47%48.71%11.28%12.07%0.70%
CMPS
COMPASS Pathways plc
-2.40%13.69%70.87%78.91%168.56%15.31%-20.57%
DFTX
Definium Therapeutics, Inc
-3.96%13.24%77.52%96.77%231.52%84.74%
ENVB
Enveric Biosciences Inc
-3.27%-34.22%-59.23%-72.39%-89.81%-87.52%-85.10%-74.86%
FMED
Fidelity Disruptive Medicine ETF
0.90%7.10%-4.75%-6.17%8.53%0.73%
FRNW
Fidelity Clean Energy ETF
0.40%-4.24%23.62%23.50%63.53%6.49%
GDX
VanEck Gold Miners ETF
6.55%-2.38%-0.58%1.22%57.71%41.18%19.97%13.81%
IBBQ
Invesco Nasdaq Biotechnology ETF
0.54%2.51%4.83%4.79%40.36%13.02%4.49%
ICLN
iShares Global Clean Energy ETF
0.80%-3.23%28.34%28.17%61.48%5.46%-0.17%11.52%
MLI
Mueller Industries, Inc.
-0.25%1.23%20.69%20.88%87.45%52.10%45.38%26.81%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 22, 2024, 22526-2's average daily return is +0.12%, while the average monthly return is +2.49%. At this rate, an investment would double in approximately 2.3 years.

Historically, 76% of months were positive and 24% were negative. The best month was Aug 2025 with a return of +10.3%, while the worst month was Mar 2026 at -8.1%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 1 months.

On a daily basis, 22526-2 closed higher 59% of trading days. The best single day was Apr 9, 2025 with a return of +7.1%, while the worst single day was Apr 4, 2025 at -6.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20266.76%8.47%-8.06%1.83%2.43%-1.35%9.55%
20255.99%1.54%3.00%-1.81%3.09%3.29%0.72%10.33%8.15%-0.72%6.38%2.43%50.70%
20240.44%9.32%-1.21%6.11%-1.99%7.40%2.48%1.94%0.52%1.50%-6.77%20.40%

Benchmark Metrics

22526-2 has an annualized alpha of 19.39%, beta of 0.71, and R2 of 0.41 versus S&P 500 Index. Calculated based on daily prices since February 22, 2024.

  • This portfolio captured 117.48% of S&P 500 Index gains but only 21.24% of its losses - a favorable profile for investors.
  • R2 of 0.41 means the benchmark explains less than half of this portfolio's behavior - treat beta with caution or consider switching to a more representative benchmark.

Alpha
19.39%
Beta
0.71
0.41
Upside Capture
117.48%
Downside Capture
21.24%

Expense Ratio

22526-2 has an expense ratio of 0.38%, placing it in the medium range. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


Top 10 holdings

Return for Risk

Risk / Return Rank

22526-2 ranks 54 for risk / return — on par with similar Portfolios. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


22526-2 Risk / Return Rank: 5454
Overall Rank
22526-2 Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
22526-2 Sortino Ratio Rank: 4545
Sortino Ratio Rank
22526-2 Omega Ratio Rank: 5757
Omega Ratio Rank
22526-2 Calmar Ratio Rank: 6363
Calmar Ratio Rank
22526-2 Martin Ratio Rank: 4141
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below presents risk-adjusted performance metrics for 22526-2 and compares them with S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PortfolioBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

2.23

2.14

+0.10

Sortino ratioReturn per unit of downside risk

2.71

2.89

-0.18

Omega ratioGain probability vs. loss probability

1.39

1.39

0.00

Calmar ratioReturn relative to maximum drawdown

3.24

2.91

+0.32

Martin ratioReturn relative to average drawdown

10.27

13.08

-2.81


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

PositionRisk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
ALKS
Alkermes plc
76
1.201.921.242.215.11
CMPS
COMPASS Pathways plc
85
1.642.361.363.329.89
DFTX
Definium Therapeutics, Inc
96
3.763.851.459.4029.57
ENVB
Enveric Biosciences Inc
11
-0.51-1.010.87-0.98-1.34
FMED
Fidelity Disruptive Medicine ETF
15
0.440.791.090.471.03
FRNW
Fidelity Clean Energy ETF
79
2.372.981.374.5015.55
GDX
VanEck Gold Miners ETF
35
1.231.651.231.604.39
IBBQ
Invesco Nasdaq Biotechnology ETF
74
2.022.851.334.8615.49
ICLN
iShares Global Clean Energy ETF
73
2.192.751.353.7713.82
MLI
Mueller Industries, Inc.
92
2.933.441.503.9410.92

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk. Learn how to interpret the Sharpe ratio.

The current 22526-2 Sharpe ratio is 2.23 as of Jun 13, 2026 (the value is recalculated daily), calculated over the past 12 months.

Compared to the broad market, where average Sharpe ratios range from 1.55 to 2.44, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of 22526-2 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading charts...

Dividends

Dividend yield

22526-2 provided a 2.59% dividend yield over the last twelve months.


PositionTTM20252024202320222021202020192018201720162015
Portfolio2.59%2.93%2.90%2.63%2.35%2.44%2.90%2.35%2.52%2.57%1.43%2.67%
ALKS
Alkermes plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CMPS
COMPASS Pathways plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DFTX
Definium Therapeutics, Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ENVB
Enveric Biosciences Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FMED
Fidelity Disruptive Medicine ETF
0.00%0.00%0.46%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FRNW
Fidelity Clean Energy ETF
1.02%1.25%1.43%1.30%0.69%0.04%0.00%0.00%0.00%0.00%0.00%0.00%
GDX
VanEck Gold Miners ETF
0.74%0.74%1.19%1.61%1.66%1.67%0.53%0.67%0.50%0.76%0.26%0.85%
IBBQ
Invesco Nasdaq Biotechnology ETF
0.84%0.90%1.14%0.81%0.76%0.63%0.00%0.00%0.00%0.00%0.00%0.00%
ICLN
iShares Global Clean Energy ETF
1.54%1.63%1.85%1.59%0.89%1.18%0.34%1.36%2.77%2.49%3.88%2.36%
MLI
Mueller Industries, Inc.
0.87%0.87%1.01%1.27%1.69%0.88%1.14%1.26%1.71%9.60%0.94%1.11%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the 22526-2. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the 22526-2 was 13.09%, occurring on Mar 20, 2026. The portfolio has not yet recovered.

The current 22526-2 drawdown is 6.30%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 correction2026
-13.09%Mar 2026
18d
3mo 16dMar 2026 - now
2025 selloff2025
-11.87%Apr 2025
5d1mo 11d
1mo 16dApr 2025 - May 2025
2024 pullback2024
-9.13%Dec 2024
1mo 27d1mo 26d
3mo 23dOct 2024 - Feb 2025
2026 pullback2026
-6.91%Feb 2026
7d21d
28dJan 2026 - Feb 2026
2024 pullback2024
-6.53%Aug 2024
21d12d
1mo 3dJul 2024 - Aug 2024

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 23 assets, with an effective number of assets of 3.29, reflecting the diversification based on asset allocation. Your portfolio is dominated by one or two holdings, which significantly increases concentration risk. Consider rebalancing toward more even weights or adding additional positions.


Diversification Ratio
1Y
All Time
Diversification Ratio

1.38

1.40

The portfolio has a diversification ratio of 1.40, in line with the typical range across portfolios. There's room to improve by adding less correlated assets.

22526-2 correlation to the S&P 500 Index

22526-2 has a 0.53 correlation to S&P 500 Index over the trailing 12 months. This section compares each holding's correlation to the benchmark and to the portfolio.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.53

Correlation (All Time)
Calculated using the full available price history since Feb 22, 2024

0.54


Benchmark Correlations

Correlation vs. S&P 500 Index. VOO has the highest benchmark correlation at 1.00, while OUNZ has the lowest at 0.16.

OUNZ
0.16
ENVB
0.21
SIVR
0.26
ALKS
0.26
GDX
0.28
DFTX
0.33
PPH
0.34
CMPS
0.35
RAAX
0.37
MRNY
0.37
VYGR
0.41
MSTY
0.45
RDIV
0.47
ICLN
0.48
FRNW
0.53
MLI
0.54
PBE
0.54
IBBQ
0.55
FMED
0.62
PBD
0.63
VXUS
0.74
SCHG
0.94
VOO
1.00

Portfolio Correlations

Correlation vs. 22526-2. GDX has the highest portfolio correlation at 0.83, while ENVB has the lowest at 0.19.

ENVB
0.19
DFTX
0.23
ALKS
0.24
CMPS
0.25
VYGR
0.30
MSTY
0.31
MRNY
0.35
PPH
0.37
SCHG
0.39
FMED
0.45
MLI
0.46
PBE
0.47
ICLN
0.48
IBBQ
0.48
FRNW
0.50
VOO
0.54
PBD
0.55
RDIV
0.56
OUNZ
0.68
VXUS
0.68
SIVR
0.71
RAAX
0.72
GDX
0.83

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

ENVBALKSOUNZDFTXCMPSSIVRMSTYPPHGDXMRNYVYGRRDIVMLIRAAXICLNSCHGFRNWPBEFMEDPBDIBBQVOOVXUS
ENVB1.000.130.030.180.150.070.130.130.070.210.180.210.150.130.170.180.210.210.260.220.200.210.17
ALKS0.131.000.030.210.180.060.150.360.080.290.340.310.260.140.200.190.200.500.400.250.500.260.24
OUNZ0.030.031.000.080.100.760.160.120.810.150.110.030.120.640.250.130.240.160.160.260.190.160.39
DFTX0.180.210.081.000.480.100.290.190.100.220.380.230.250.210.240.320.270.400.380.280.440.330.29
CMPS0.150.180.100.481.000.160.270.180.140.300.410.220.190.170.260.330.300.360.400.360.460.350.34
SIVR0.070.060.760.100.161.000.210.110.770.190.130.070.140.530.300.240.310.190.190.360.220.260.47
MSTY0.130.150.160.290.270.211.000.060.220.230.320.220.280.250.300.470.370.290.330.420.310.450.38
PPH0.130.360.120.190.180.110.061.000.160.320.310.400.240.190.230.210.230.610.530.260.640.340.41
GDX0.070.080.810.100.140.770.220.161.000.180.140.100.210.600.370.240.360.230.240.370.260.280.50
MRNY0.210.290.150.220.300.190.230.320.181.000.410.310.300.220.310.310.330.500.490.410.580.370.40
VYGR0.180.340.110.380.410.130.320.310.140.411.000.300.290.170.260.370.320.500.490.370.590.410.37
RDIV0.210.310.030.230.220.070.220.400.100.310.301.000.520.390.320.250.360.470.420.410.450.470.44
MLI0.150.260.120.250.190.140.280.240.210.300.290.521.000.360.320.420.380.420.420.430.390.530.48
RAAX0.130.140.640.210.170.530.250.190.600.220.170.390.361.000.390.250.420.270.260.430.290.370.49
ICLN0.170.200.250.240.260.300.300.230.370.310.260.320.320.391.000.410.920.360.350.800.400.480.61
SCHG0.180.190.130.320.330.240.470.210.240.310.370.250.420.250.411.000.470.450.570.560.460.940.64
FRNW0.210.200.240.270.300.310.370.230.360.330.320.360.380.420.920.471.000.370.400.870.420.530.66
PBE0.210.500.160.400.360.190.290.610.230.500.500.470.420.270.360.450.371.000.760.450.890.540.51
FMED0.260.400.160.380.400.190.330.530.240.490.490.420.420.260.350.570.400.761.000.480.790.620.56
PBD0.220.250.260.280.360.360.420.260.370.410.370.410.430.430.800.560.870.450.481.000.490.630.76
IBBQ0.200.500.190.440.460.220.310.640.260.580.590.450.390.290.400.460.420.890.790.491.000.550.53
VOO0.210.260.160.330.350.260.450.340.280.370.410.470.530.370.480.940.530.540.620.630.551.000.74
VXUS0.170.240.390.290.340.470.380.410.500.400.370.440.480.490.610.640.660.510.560.760.530.741.00
The correlation results are calculated based on daily price changes starting from Feb 22, 2024
Diversification Analysis

Find what 22526-2 is missing

See which holdings overlap, where 22526-2 is concentrated, and which low-correlation assets could fill the gaps.

Analyze Diversification